Doximity, Inc. $DOCS Shares Acquired by Csenge Advisory Group

Csenge Advisory Group lifted its stake in Doximity, Inc. (NASDAQ:DOCS) by 91.0% during the third quarter, HoldingsChannel reports. The institutional investor owned 26,971 shares of the company’s stock after acquiring an additional 12,852 shares during the period. Csenge Advisory Group’s holdings in Doximity were worth $1,973,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. GAMMA Investing LLC grew its holdings in shares of Doximity by 5.9% during the second quarter. GAMMA Investing LLC now owns 2,981 shares of the company’s stock worth $183,000 after purchasing an additional 165 shares during the last quarter. Louisiana State Employees Retirement System boosted its position in shares of Doximity by 0.5% in the 2nd quarter. Louisiana State Employees Retirement System now owns 37,600 shares of the company’s stock valued at $2,306,000 after purchasing an additional 200 shares during the period. Oregon Public Employees Retirement Fund grew its stake in Doximity by 0.7% during the 3rd quarter. Oregon Public Employees Retirement Fund now owns 27,500 shares of the company’s stock worth $2,012,000 after buying an additional 200 shares during the last quarter. Fairvoy Private Wealth LLC increased its position in Doximity by 1.1% during the third quarter. Fairvoy Private Wealth LLC now owns 19,253 shares of the company’s stock worth $1,408,000 after buying an additional 206 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Doximity by 0.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company’s stock valued at $2,262,000 after buying an additional 210 shares during the last quarter. 87.19% of the stock is owned by hedge funds and other institutional investors.

Doximity Stock Up 0.5%

NASDAQ DOCS opened at $41.25 on Friday. The stock has a market capitalization of $7.77 billion, a P/E ratio of 41.25, a P/E/G ratio of 4.10 and a beta of 1.39. Doximity, Inc. has a 52-week low of $39.95 and a 52-week high of $85.21. The firm has a 50-day moving average price of $46.35 and a 200 day moving average price of $59.12.

Doximity (NASDAQ:DOCS) last released its earnings results on Thursday, November 6th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.07. Doximity had a return on equity of 21.75% and a net margin of 36.60%.Doximity’s revenue was up 23.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.30 EPS. On average, equities research analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $66.44, for a total value of $132,880.00. Following the completion of the transaction, the director owned 19,839 shares in the company, valued at approximately $1,318,103.16. This represents a 9.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 31.30% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the stock. Morgan Stanley upgraded shares of Doximity from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $62.00 to $65.00 in a research report on Monday, December 15th. Canaccord Genuity Group set a $48.00 price objective on shares of Doximity in a research report on Thursday, January 8th. Truist Financial set a $62.00 price objective on shares of Doximity in a research note on Thursday, January 8th. JPMorgan Chase & Co. reiterated an “underweight” rating and set a $62.00 target price on shares of Doximity in a research note on Friday, October 10th. Finally, Raymond James Financial reissued a “strong-buy” rating on shares of Doximity in a report on Monday, December 29th. Two analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Doximity currently has an average rating of “Moderate Buy” and an average target price of $66.11.

About Doximity

Doximity, Inc, headquartered in San Francisco, California, operates the leading professional medical network for healthcare professionals in the United States. Founded in 2011 by Jeff Tangney and Shari Buck, the company set out to create a secure digital environment where physicians, nurse practitioners and physician assistants can collaborate, share information and stay current with clinical news. Doximity went public in June 2021 and trades on the NASDAQ under the ticker symbol “DOCS.”

The core offering of Doximity is its HIPAA-compliant communication platform, which includes a secure messaging system, digital fax services and telehealth capabilities.